<DOC>
	<DOCNO>NCT01598311</DOCNO>
	<brief_summary>608 patient Clostridium Difficile Associated Diarrhea ( CDAD ) participate study receive either oral vancomycin CB-183,315 blind fashion . Treatment last 10 day participant follow least 40 day maximum 100 day . The purpose study evaluate well CB-183,315 treat CDAD compare vancomycin .</brief_summary>
	<brief_title>A Study CB-183,315 Patients With Clostridium Difficile Associated Diarrhea</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<criteria>To include study , participant must : Sign consent form ; Be old 18 old 90 young ; Have diarrhea , least 3 time one day , 200 mL liquid stool use rectal device ; Test positive Clostridium difficile ; If female , must pregnant nurse take appropriate measure get pregnant study . Participants allow study : Have toxic megacolon and/or know small bowel ileus ; Have receive treatment intravenous immune globulin ( IVIG ) within past 30 day ; Have receive treatment fecal transplant within 7 day , and/or doctor anticipates give participant fecal transplant study ; Have receive certain amount antibacterial therapy specific current CDAD , unless work ; Have receive investigational vaccine C. difficile ; Have receive investigational product contain monoclonal antibody toxin A B within 180 day ; Had 2 episode CDAD within 90 day ; Had major gastrointestinal ( GI ) surgery ( i.e . significant bowel resection ) within 3 month ( include appendectomy cholecystectomy ) ; Have history prior inflammatory bowel disease : ulcerative colitis , Crohn 's disease , microscopic colitis ; Are unable discontinue loperamide , diphenoxylate/atropine , cholestyramine duration study ; Are unable discontinue opiate treatment unless stable dose ; Has know positive stool culture enteropathogens include limited Salmonella , Shigella , Campylobacter ; Had stool study positive pathogenic ovum and/or parasite ; Have intolerance hypersensitivity daptomycin and/or vancomycin ; Have lifethreatening illness time enrollment ; Have poor concurrent medical risk opinion Investigator participant enroll ; Have receive investigational drug participate experimental procedure within 1 month ; Have HIV , CD4 &lt; 200 cells/mm3 within 6 month start study therapy ; Anticipate certain antibacterial therapy nonCDAD infection require &gt; 7 day ; Are unable discontinue Saccharomyces similar probiotic ; Are concurrent intensive induction chemotherapy , radiotherapy , biologic treatment active malignancy ; Are unable comply protocol requirement ; Have condition , opinion Investigator , might interfere ; Are expect live less 8 week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>CDAD</keyword>
	<keyword>Clostridium difficile Associated Diarrhea</keyword>
	<keyword>CDI</keyword>
	<keyword>Clostridium difficile Infection</keyword>
	<keyword>Diarrhea</keyword>
</DOC>